MORGAN STANLEY PLC/PUT/ZOETIS/150/0.1/19.12.25 | Market Closed - Börse Stuttgart 19:48:36 25/06/2024 BST | ||
| 1.73 EUR | +6.13% |
|
| Current month | +13.82% | ||
| 1 month | +14.57% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ZOETIS INC.
Latest news about ZOETIS INC.
More news
| Date | Price | Change |
|---|---|---|
| 25/06/24 | 1.73 | +6.13% |
| 24/06/24 | 1.63 | -2.40% |
| 21/06/24 | 1.67 | -6.18% |
| 20/06/24 | 1.78 | +0.56% |
| 19/06/24 | 1.77 | +9.94% |
Delayed Quote Börse Stuttgart
Last update June 25, 2024 at 07:48 pm
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | PUT |
| Underlying | ZOETIS INC. |
| Issuer | Morgan Stanley |
| WKN | ME4GES |
| ISIN | DE000ME4GES2 |
| Date issued | 01/12/2023 |
| Strike | 150 $ |
| Maturity | 19/12/2025 (542 Days) |
| Parity | 10 : 1 |
| Emission price | 1.14 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 2.28 € |
|---|---|
| Lowest since issue | 1.06 € |
| Spread | 0.03 € |
| Spread % | 1.69% |
Company Profile
Zoetis Inc. specializes in developing, manufacturing and marketing of animal health products. Net sales break down by activity as follows:
- pets (64.4%): cats and dogs (94.9% of net sales) and horses (5.1%);
- livestock (34.5%): cattle (51.6% of sales), swine (20.2%), poultry (17.1%), fish (7.6%) and other (3.5%);
- other (1.1%).
Net sales break down by family of products into parasiticides (23%), vaccines (21.3%), dermatological products (16.4%), anti-infectives (13.4%), medical food additives (4.5%), diagnostic products (4.4%) and other (17%).
At the end of 2022, the group has 29 production sites worldwide.
The United States accounts for 53.4% of net sales.
Sector
-
Consensus: Zoetis Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
168
USD
Average target price
210.2
USD
Spread / Average Target
+25.10%
- Stock Market
- Warrants
- Warrant
